Morgan Stanley’s Lifecore Biomedical LFCR Stock Holding History

Morgan Stanley’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.84M	Buy	764,734 +13,229	+2%	+$91.3K	﹤0.01%	4504
2025 Q4	$6.15M	Buy	751,505 +41,806	+6%	+$309K	﹤0.01%	4026
2025 Q3	$5.22M	Sell	709,699 -30,109	-4%	-$228K	﹤0.01%	4115
2025 Q2	$6.01M	Buy	739,808 +11,297	+2%	+$76.2K	﹤0.01%	3905
2025 Q1	$5.13M	Sell	728,511 -16,674	-2%	-$104K	﹤0.01%	3905
2024 Q4	$5.54M	Sell	745,185 -31,505	-4%	-$201K	﹤0.01%	3909
2024 Q3	$3.83M	Buy	776,690 +30,456	+4%	+$159K	﹤0.01%	4168
2024 Q2	$3.83M	Sell	746,234 -45,573	-6%	-$270K	﹤0.01%	4105
2024 Q1	$4.2M	Sell	791,807 -785,597	-50%	-$5.62M	﹤0.01%	4042
2023 Q4	$9.76M	Buy	1,577,404 +782,463	+98%	+$5.43M	﹤0.01%	3936
2023 Q3	$6M	Sell	794,941 -22,553	-3%	-$206K	﹤0.01%	3590
2023 Q2	$7.91M	Sell	817,494 -51,606	-6%	-$315K	﹤0.01%	3395
2023 Q1	$3.28M	Buy	869,100 +229,501	+36%	+$1.28M	﹤0.01%	4120
2022 Q4	$4.14M	Buy	639,599 +24,562	+4%	+$202K	﹤0.01%	3916
2022 Q3	$5.47M	Buy	615,037 +6,246	+1%	+$63.5K	﹤0.01%	3608
2022 Q2	$6.07M	Buy	608,791 +18,911	+3%	+$187K	﹤0.01%	3583
2022 Q1	$6.83M	Sell	589,880 -11,897	-2%	-$132K	﹤0.01%	3340
2021 Q4	$6.68M	Buy	601,777 +10,572	+2%	+$103K	﹤0.01%	3411
2021 Q3	$5.45M	Buy	591,205 +556,091	+1,584%	+$6.05M	﹤0.01%	3593
2021 Q2	$394K	Buy	35,114 +20,117	+134%	+$232K	﹤0.01%	5674
2021 Q1	$159K	Sell	14,997 -170,446	-92%	-$1.92M	﹤0.01%	5784
2020 Q4	$2.01M	Sell	185,443 -49,190	-21%	-$508K	﹤0.01%	4156
2020 Q3	$2.28M	Sell	234,633 -140,008	-37%	-$1.33M	﹤0.01%	3543
2020 Q2	$2.98M	Buy	374,641 +320,043	+586%	+$3.3M	﹤0.01%	3199
2020 Q1	$474K	Sell	54,598 -46,989	-46%	-$489K	﹤0.01%	4401
2019 Q4	$1.15M	Sell	101,587 -23,123	-19%	-$246K	﹤0.01%	4448
2019 Q3	$1.36M	Buy	124,710 +72,380	+138%	+$788K	﹤0.01%	4099
2019 Q2	$492K	Buy	52,330 +44,257	+548%	+$447K	﹤0.01%	4614
2019 Q1	$100K	Sell	8,073 -89,651	-92%	-$1.09M	﹤0.01%	5395
2018 Q4	$1.16M	Buy	97,724 +14,217	+17%	+$195K	﹤0.01%	4179
2018 Q3	$1.2M	Buy	83,507 +12,012	+17%	+$166K	﹤0.01%	4393
2018 Q2	$1.07M	Sell	71,495 -1,964	-3%	-$27.3K	﹤0.01%	4596
2018 Q1	$958K	Buy	73,459 +3,463	+5%	+$45.5K	﹤0.01%	4572
2017 Q4	$882K	Buy	69,996 +18,549	+36%	+$234K	﹤0.01%	4624
2017 Q3	$666K	Buy	51,447 +20,590	+67%	+$271K	﹤0.01%	4698
2017 Q2	$459K	Sell	30,857 -6,255	-17%	-$87.1K	﹤0.01%	4857
2017 Q1	$446K	Sell	37,112 -42,354	-53%	-$536K	﹤0.01%	4910
2016 Q4	$1.1M	Buy	79,466 +72,438	+1,031%	+$1M	﹤0.01%	4393
2016 Q3	$94K	Buy	7,028 +6,028	+603%	+$73K	﹤0.01%	5330
2016 Q2	$10K	Sell	1,000 -13,869	-93%	-$153K	﹤0.01%	6061
2016 Q1	$156K	Buy	14,869 +12,183	+454%	+$134K	﹤0.01%	5108
2015 Q4	$32K	Sell	2,686 -34,873	-93%	-$428K	﹤0.01%	5877
2015 Q3	$439K	Buy	37,559 +30,466	+430%	+$404K	﹤0.01%	4683
2015 Q2	$103K	Sell	7,093 -165,785	-96%	-$2.39M	﹤0.01%	5568
2015 Q1	$2.41M	Sell	172,878 -118,597	-41%	-$1.64M	﹤0.01%	3424
2014 Q4	$4.03M	Sell	291,475 -1,423	-0.5%	-$18.4K	﹤0.01%	2931
2014 Q3	$3.59M	Buy	292,898 +4,873	+2%	+$60.8K	﹤0.01%	2931
2014 Q2	$3.6M	Buy	288,025 +9,340	+3%	+$110K	﹤0.01%	2981
2014 Q1	$3.11M	Buy	278,685 +14,185	+5%	+$156K	﹤0.01%	3039
2013 Q4	$3.21M	Buy	264,500 +217,719	+465%	+$2.6M	﹤0.01%	2987
2013 Q3	$571K	Sell	46,781 -34,300	-42%	-$479K	﹤0.01%	4240
2013 Q2	$1.07M	Buy	+81,081	New	+$1.12M	﹤0.01%	3678

Other funds holding LFCR

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return